PanGIA Biotech, Inc.
PrivateLast Round
Convertible Debt
May 11, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PanGIA Biotech, Inc. is a biotechnology company that develops an AI-integrated, urine- and CSF-based liquid biopsy platform for the non-invasive detection of cancer and other complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PanGIA Biotech, Inc. Comparables
Compare PanGIA Biotech, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Craif Inc. | 77% | |
| AOA Dx | 73% | |
| Caris Life Sciences | 72% |
PanGIA Biotech, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | May 11, 2026 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
$1.58M raised in convertible debt.
- Oct 15, 2025
Grew 57% QoQ from 7 to 11 employees.
PanGIA Biotech, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PanGIA Biotech, Inc.'s valuation, stock price, and market status.
Is PanGIA Biotech, Inc. a public or private company?
PanGIA Biotech, Inc. is a private company.
What is the current stock price of PanGIA Biotech, Inc.?
PanGIA Biotech, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is PanGIA Biotech, Inc. worth (valuation)?
Valuation information for PanGIA Biotech, Inc. is not publicly available.
Can I buy PanGIA Biotech, Inc. stock?
PanGIA Biotech, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PanGIA Biotech, Inc.'s last funding round?
PanGIA Biotech, Inc.'s most recent funding round was Convertible Debt on May 11, 2026.
Who are the main investors in PanGIA Biotech, Inc.?
Investor information for PanGIA Biotech, Inc. is not publicly disclosed.
Will PanGIA Biotech, Inc. IPO soon?
No public IPO plans have been announced for PanGIA Biotech, Inc..
How can I track PanGIA Biotech, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PanGIA Biotech, Inc.'s secondary market activity and sign up for updates.